Status:
COMPLETED
Virtual Reality and Brain Stimulation, an Experiential Approach
Lead Sponsor:
Nantes University Hospital
Conditions:
Acrophobia
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The aim of this study is to assess feasibility, acceptability and efficacy of two VRET (Virtual Reality Exposition Therapy)session associated with either active anodal tDCS or sham tDCS on the ventrom...
Detailed Description
Subjects suffering from visual height intolerance are asked to go in 20 min as height as possible riding in two elevators of adjacents buildings separated by a board they have to cross at each stage. ...
Eligibility Criteria
Inclusion
- Without any particular ethnic and psychosocial criteria
- Subjects with fear of heights (anxiety AQ score \>45 and/or VHI score \>7)
- Subjects with SUD score\>50/100 assessed during first visit
- Subjects without psychiatric or addictive disorders
- Subjects without criteria of phobia according to DSM5 (Diagnostic Statistical Manual)
Exclusion
- contraindication to tDCS (neurosurgical history, intracranial device, skin problems)
- current virtual reality intolerance
- history of psychiatric or addictive disorders
- Use of psychotropic drugs
- Use of non psychotropic treatments significantly influencing mood or level of anxiety
- Neurological pathology, locomotor disability, or sensory (vestibular, visual, auditory ...)
- pregnant or breast-feeding women
Key Trial Info
Start Date :
June 4 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 27 2018
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT03387254
Start Date
June 4 2018
End Date
July 27 2018
Last Update
July 30 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital
Nantes, France